Adynxx Inc
Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-… Read more
Adynxx Inc (ADYX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2019: 0.049x
Based on the latest financial reports, Adynxx Inc (ADYX) has a cash flow conversion efficiency ratio of 0.049x as of September 2019.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-544.00K) by net assets ($-11.06 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Adynxx Inc - Cash Flow Conversion Efficiency Trend (2000–2018)
This chart illustrates how Adynxx Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Adynxx Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Adynxx Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HIPPO VALLEY ESTATES LIMITED
XZIM:HIPO
|
N/A |
|
Peer To Peer Network
PINK:PTOP
|
0.045x |
|
Bright Kindle Resources & Investments Inc
PSE:BKR
|
-0.007x |
|
First Abacus Financial Holdings Corp
PSE:FAF
|
0.058x |
|
HAW Capital Corp
V:HAW-P
|
-0.016x |
|
Mushrooms Inc.
PINK:MSRM
|
0.003x |
|
Winchester Equity Corporation
V:WEC
|
N/A |
|
BANK INTL INDON -A-
BE:BOZA
|
-0.376x |
Annual Cash Flow Conversion Efficiency for Adynxx Inc (2000–2018)
The table below shows the annual cash flow conversion efficiency of Adynxx Inc from 2000 to 2018.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2018-12-31 | $8.25 Million | $-9.71 Million | -1.177x | -72.74% |
| 2017-12-31 | $15.67 Million | $-10.67 Million | -0.681x | -19.22% |
| 2016-12-31 | $32.09 Million | $-18.34 Million | -0.571x | -38.53% |
| 2015-12-31 | $52.42 Million | $-21.62 Million | -0.412x | +30.15% |
| 2014-12-31 | $22.51 Million | $-13.29 Million | -0.590x | -72.74% |
| 2013-12-31 | $13.95 Million | $-4.77 Million | -0.342x | -111.24% |
| 2012-12-31 | $12.15 Million | $-1.97 Million | -0.162x | -0.42% |
| 2011-12-31 | $13.63 Million | $-2.20 Million | -0.161x | -133.37% |
| 2010-12-31 | $24.82 Million | $-1.71 Million | -0.069x | +61.62% |
| 2009-12-31 | $6.53 Million | $-1.17 Million | -0.180x | +73.80% |
| 2008-12-31 | $2.89 Million | $-1.98 Million | -0.686x | -119.65% |
| 2007-12-31 | $-542.53K | $-1.90 Million | 3.494x | +160.01% |
| 2006-12-31 | $-1.06 Million | $-1.42 Million | 1.344x | +26.02% |
| 2005-12-31 | $-1.25 Million | $-1.33 Million | 1.066x | -57.88% |
| 2004-12-31 | $-538.95K | $-1.36 Million | 2.531x | +22.53% |
| 2003-12-31 | $-494.96K | $-1.02 Million | 2.066x | +150.94% |
| 2002-12-31 | $26.66K | $-108.13K | -4.055x | -2033.40% |
| 2001-12-31 | $78.04K | $-14.83K | -0.190x | +26.09% |
| 2000-12-31 | $104.40K | $-26.85K | -0.257x | -- |